Iyuzeh (Latanoprost Ophthalmic Solution 0.005%) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Iyuzeh. Always confirm against the full prescribing information.
43 interactions
Baricitinib
The serum concentration of Baricitinib can be increased when it is combined with Latanoprost.
Level 1 evidence
Pemetrexed
Latanoprost may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Level 1 evidence
Sulopenem etzadroxil
The serum concentration of Sulopenem etzadroxil can be increased when it is combined with Latanoprost.
Level 1 evidence
Thimerosal
Thimerosal can cause a decrease in the absorption of Latanoprost resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Vadadustat
The serum concentration of Vadadustat can be increased when it is combined with Latanoprost.
Level 1 evidence
Aceclofenac
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Aceclofenac.
Level 2 evidence
Acetylsalicylic acid
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Acetylsalicylic acid.
Level 2 evidence
Antipyrine
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Antipyrine.
Level 2 evidence
Balsalazide
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Balsalazide.
Level 2 evidence
Celecoxib
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Celecoxib.
Level 2 evidence
Diclofenac
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Diclofenac.
Level 2 evidence
Diflunisal
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Diflunisal.
Level 2 evidence
Enter your NPI to unlock 2 major interactions for Iyuzeh
Iyuzeh (Latanoprost Ophthalmic Solution 0.005%) has 43 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Iyuzeh (Latanoprost Ophthalmic Solution 0.005%) has 2 major, 5 moderate, and 36 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Iyuzeh. Always confirm against the full prescribing information.